Self-expanding polyethylene terephthalate and polytetrafluoroethylene (PTFE)-covered stents have been shown to decrease the need for repeat procedures in the iliac artery. [33] Similar to surgical ...

NATICK, Mass., Boston Scientific Corporation today announced that it has completed enrollment in the ORION clinical trial, which is designed to evaluate the Company's EPIC™ Self-Expanding Nitinol ...

MOBILITY Trial Demonstrated Absolute Pro to be Safe and Effective in Patients with Peripheral Artery Disease in the Lower Extremities Abbott Park, Illinois — Abbott today announced that the U.S. Food ...

Cordis announced the FDA has approved its self-expanding vascular stent designed for transradial peripheral procedures in the iliac and superficial femoral arteries. The self-expanding stent ...

Boston Scientific Corp. has announced it has received FDA approval and market launch of its Epic vascular self-expanding stent system, according to a news release. Boston Scientific said the Epic ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/9r4nlm/medipoint) has announced the addition of the "MediPoint: Peripheral ...

The aorta is the main blood vessel that carries oxygen-filled blood from the heart to the rest of the body. It extends from the chest to the abdomen, where it branches (bifurcates) into the iliac ...

As you may be aware, the heart’s arteries are not rigid pipes; they’re living structures that twist, flex, constrict, expand, ...

The US Food and Drug Administration (FDA) has approved Abbott's Absolute Pro Vascular Self-Expanding Stent System for the treatment of iliac artery disease, a form of peripheral artery disease (PAD) ...

The treatment of patients with peripheral arterial disease has evolved tremendously since the early 1960s, when Charles Dotter first successfully revascularized a superficial femoral artery occlusion ...